相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Carbonic anhydrase 9 immunohistochemistry as a tool to predict or validate germline and somatic VHL mutations in pheochromocytoma and paraganglioma-a retrospective and prospective study
Judith Favier et al.
MODERN PATHOLOGY (2020)
Morphologic Clues to Succinate Dehydrogenase (SDH) Deficiency in Pheochromocytomas and Paragangliomas
John Turchini et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2020)
Recent advances in the biology of tumour hypoxia with relevance to diagnostic practice and tissue-based research
Philip S. Macklin et al.
JOURNAL OF PATHOLOGY (2020)
Immunohistochemical Analysis of the Metabolic Phenotype of Adrenal Cortical Carcinoma
Kai Duan et al.
ENDOCRINE PATHOLOGY (2020)
Metabolomics, machine learning and immunohistochemistry to predict succinate dehydrogenase mutational status in phaeochromocytomas and paragangliomas
Paal W. Wallace et al.
JOURNAL OF PATHOLOGY (2020)
Metabolomic Urine Profile: Searching for New Biomarkers of SDHx-Associated Pheochromocytomas and Paragangliomas
Raquel G. Martins et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Recurrent Germline DLST Mutations in Individuals with Multiple Pheochromocytomas and Paragangliomas
Laura Remacha et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2019)
Immunohistochemical Biomarkers of Adrenal Cortical Neoplasms
Ozgur Mete et al.
ENDOCRINE PATHOLOGY (2018)
Old, New, and Emerging Immunohistochemical Markers in Pheochromocytoma and Paraganglioma
Veronica K. Y. Cheung et al.
ENDOCRINE PATHOLOGY (2018)
The utility of SDHB and FH immunohistochemistry in patients evaluated for hereditary paraganglioma-pheochromocytoma syndromes
Aaron M. Udager et al.
HUMAN PATHOLOGY (2018)
The Diagnosis and Clinical Significance of Paragangliomas in Unusual Locations
Sylvia L. Asa et al.
JOURNAL OF CLINICAL MEDICINE (2018)
Routine genetic screening with a multi-gene panel in patients with pheochromocytomas
Emilia Sbardella et al.
ENDOCRINE (2018)
Pathological and Genetic Characterization of Bilateral Adrenomedullary Hyperplasia in a Patient with Germline MAX Mutation
Pauline Romanet et al.
ENDOCRINE PATHOLOGY (2017)
Consensus Statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas
Rodrigo A. Toledo et al.
NATURE REVIEWS ENDOCRINOLOGY (2017)
Characteristics of Pediatric vs Adult Pheochromocytomas and Paragangliomas
Christina Pamporaki et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Potential Pitfalls of SDH Immunohistochemical Detection in Paragangliomas and Phaeochromocytomas Harbouring Germline SDHx Gene Mutation
Raffaella Santi et al.
ANTICANCER RESEARCH (2017)
Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma
Lauren Fishbein et al.
CANCER CELL (2017)
TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data
Antonio Colaprico et al.
NUCLEIC ACIDS RESEARCH (2016)
Hypoxia Pathway Mutations in Pheochromocytomas and Paragangliomas
Diana Amorim-Pires et al.
CYTOGENETIC AND GENOME RESEARCH (2016)
Hypoxia-Inducible Factor 2α Mutation-Related Paragangliomas Classify as Discrete Pseudohypoxic Subcluster
Stephanie M. J. Fliedner et al.
NEOPLASIA (2016)
SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T)
Thomas G. Papathomas et al.
MODERN PATHOLOGY (2015)
Metabolome Profiling by HRMAS NMR Spectroscopy of Pheochromocytomas and Paragangliomas Detects SDH Deficiency: Clinical and Pathophysiological Implications
Alessio Imperiale et al.
NEOPLASIA (2015)
Protocol for the Examination of Specimens From Patients With Pheochromocytomas and Extra-Adrenal Paragangliomas
Ozgur Mete et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2014)
Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas
Luis Jaime Castro-Vega et al.
HUMAN MOLECULAR GENETICS (2014)
Krebs Cycle Metabolite Profiling for Identification and Stratification of Pheochromocytomas/Paragangliomas due to Succinate Dehydrogenase Deficiency
Susan Richter et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Immunohistochemical markers of the hypoxic response can identify malignancy in phaeochromocytomas and paragangliomas and optimize the detection of tumours with VHL germline mutations
D. J. Pinato et al.
BRITISH JOURNAL OF CANCER (2013)
SDH Mutations Establish a Hypermethylator Phenotype in Paraganglioma
Eric Letouze et al.
CANCER CELL (2013)
Usefulness of Negative and Weak-Diffuse Pattern of SDHB Immunostaining in Assessment of SDH Mutations in Paragangliomas and Pheochromocytomas
Esmeralda Castelblanco et al.
ENDOCRINE PATHOLOGY (2013)
Inhibin-expressing clear cell neuroendocrine tumor of the ampulla: an unusual presentation of von Hippel-Lindau disease
Hasan Gucer et al.
VIRCHOWS ARCHIV (2013)
Genotype and Tumor Locus Determine Expression Profile of Pseudohypoxic Pheochromocytomas and Paragangliomas
Uma Shankavaram et al.
NEOPLASIA (2013)
Diagnostic Tests and Biomarkers for Pheochromocytoma and Extra-adrenal Paraganglioma: From Routine Laboratory Methods to Disease Stratification
Graeme Eisenhofer et al.
ENDOCRINE PATHOLOGY (2012)
From Transcriptional Profiling to Tumor Biology in Pheochromocytoma and Paraganglioma
Alberto Cascon et al.
ENDOCRINE PATHOLOGY (2012)
Signaling Pathways in Pheochromocytomas and Paragangliomas: Prospects for Future Therapies
Svenja Noelting et al.
ENDOCRINE PATHOLOGY (2012)
Diagnostic Role of Inhibin α-Subunit and Inhibin/Activin β-Subunit in Adrenal Cortical and Medullary Tumors in Egyptian Patients
Hanan Mohammed Abd Elmoneim et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2012)
Measurements of Plasma Methoxytyramine, Normetanephrine, and Metanephrine as Discriminators of Different Hereditary Forms of Pheochromocytoma
Graeme Eisenhofer et al.
CLINICAL CHEMISTRY (2011)
SDHA Immunohistochemistry Detects Germline SDHA Gene Mutations in Apparently Sporadic Paragangliomas and Pheochromocytomas
Esther Korpershoek et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
A Tissue Microarray-based Comparative Analysis of Novel and Traditional Immunohistochemical Markers in the Distinction Between Adrenal Cortical Lesions and Pheochromocytoma
Ankur R. Sangoi et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)
edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
Mark D. Robinson et al.
BIOINFORMATICS (2010)
Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes
Anthony J. Gill et al.
HUMAN PATHOLOGY (2010)
Research Resource: Transcriptional Profiling Reveals Different Pseudohypoxic Signatures in SDHB and VHL-Related Pheochromocytomas
Elena Lopez-Jimenez et al.
MOLECULAR ENDOCRINOLOGY (2010)
Expression of activin and inhibin subunits, receptors and binding proteins in human pheochromocytomas: a study based on mRNA analysis and immunohistochemistry
J. Hofland et al.
CLINICAL ENDOCRINOLOGY (2007)
Follicle-stimulating hormone activation of hypoxia-inducible factor-1 by the phosphatidylinositol 3-kinase/AKT/Ras homolog enriched in brain (Rheb)/mammalian target of rapamycin (mTOR) pathway is necessary for induction of select protein markers of follicular differentiation
H Alam et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The role of calretinin, inhibin, melan-A, BCL-2, and C-kit in differentiating adrenal cortical and medullary tumors: An immunohistochemical study
PJ Zhang et al.
MODERN PATHOLOGY (2003)
Clear cell carcinoid tumor of the gallbladder - Another distinctive manifestation of von Hippel-Lindau disease
PA Sinkre et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2001)
Expression of inhibin α in adrenocortical tumours reflects the hormonal status of the neoplasm
J Arola et al.
JOURNAL OF ENDOCRINOLOGY (2000)
分享论文
